Back

Improvement in central haemodynamic parameters by association of angiotensin II receptors blockers and canrenone therapy in obese hypertensive patients

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Renin-angiotensin-aldosterone antagonists Renin-angiotensin-aldosterone antagonists HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Carlos Alberto Paterno Marchioli

Cardiovascular Research Laboratory., Castiglion Fiorentino (AR) (Italy)

3 More presentations in this session

Presentation thumbnail
Safety and benefits of the use of an uptitration protocol in patients with heart failure and reduced ejection fraction followed in an heart failure unit
Doctor A. Giraldez Valpuesta (Jerez de la Frontera, ES)
Abstract
Presentation thumbnail
Mineralocorticoid receptor antagonists: do we use them enough in very elderly patients with heart failure and severe left ventricular dysfunction?
Miss M. Martin Mariscal (Madrid, ES)
Abstract Slides
Presentation thumbnail
Causes and impact on survival of omission of ACE-inhibitors and angiotensin II receptor blockers in heart failure.
Associate Professor P. Ameri (Genova, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Renin-angiotensin-aldosterone antagonists

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources